Coronary artery bypass grafting (CABG) is the clear preferred revascularisation method for patients with diabetes and multivessel coronary artery disease, a new review has concluded. While percutaneous coronary intervention (PCI) is increasingly preferred for many patient groups, there is still a clear superiority in terms of mortality in patients with diabetes, a pooled analysis of ...
For coronary patients with diabetes, CABG is the treatment of choice
By Michael Woodhead
1 Mar 2018